sulfamethoxazole has been researched along with Deafness in 1 studies
Sulfamethoxazole: A bacteriostatic antibacterial agent that interferes with folic acid synthesis in susceptible bacteria. Its broad spectrum of activity has been limited by the development of resistance. (From Martindale, The Extra Pharmacopoeia, 30th ed, p208)
sulfamethoxazole : An isoxazole (1,2-oxazole) compound having a methyl substituent at the 5-position and a 4-aminobenzenesulfonamido group at the 3-position.
Deafness: A general term for the complete loss of the ability to hear from both ears.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 1 (100.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Cooper, J | 1 |
| Inman, JS | 1 |
| Dawson, AF | 1 |
1 trial available for sulfamethoxazole and Deafness
| Article | Year |
|---|---|
A comparison between co-trimoxazole and amoxycillin in the treatment of acute otitis media in general practice.
Topics: Adolescent; Adult; Amoxicillin; Ampicillin; Child; Child, Preschool; Clinical Trials as Topic; Deafn | 1976 |